Clinical Trials

NCT IdNCT04871945
TitleProtective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis
ConditionCovid19
StudyTypeObservational
OrganizationHanyang University Seoul Hospital
Sponsor/CollaboratorsHanyang University Seoul Hospital
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Hanyang University Seoul Hospital, Seoul, Korea, Republic of
DescriptionThe aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.